Cargando…

Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections

BACKGROUND: Although the clinical features of Acinetobacter baumannii bloodstream infection are well described, the specific clinical characteristics of polymicrobial Acinetobacter baumannii bloodstream infection have been rarely reported. The objective of this study was to examine the risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Zhenhua, Zhang, Shufang, Li, Na, Ma, Weixing, Zhang, Kai, Song, Feizhen, Zheng, Cheng, Zhong, Li, Wang, Yesong, Cai, Jiachang, Zhou, Hongwei, Cui, Wei, Zhang, Gensheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898812/ https://www.ncbi.nlm.nih.gov/pubmed/35265714 http://dx.doi.org/10.1155/2022/5122085

Ejemplares similares

Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections
por: Song, Feizhen, et al.
Publicado: (2021)

Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections
por: Zheng, Cheng, et al.
Publicado: (2020)

Correction: Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections
por: Zheng, Cheng, et al.
Publicado: (2022)

Clinical Characteristics And Risk Factors In Mixed-Enterococcal Bloodstream Infections
por: Zheng, Cheng, et al.
Publicado: (2019)

Clinical characteristics, risk factors and outcomes of mixed Candida albicans/bacterial bloodstream infections
por: Zhong, Li, et al.
Publicado: (2020)

Multidrug-Resistant Acinetobacter baumannii May Cause Patients to Develop Polymicrobial Bloodstream Infection
por: Chen, Qingqing, et al.
Publicado: (2022)

Is Polymicrobial Bacteremia an Independent Risk Factor for Mortality in Acinetobacter baumannii Bacteremia?
por: Wang, Yung-Chih, et al.
Publicado: (2020)

Clinical characteristics of and risk factors for secondary bloodstream infection after pneumonia among patients infected with methicillin-resistant Staphylococcus aureus
por: Huang, Fangfang, et al.
Publicado: (2022)

Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study
por: Zhong, Li, et al.
Publicado: (2022)

Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection
por: Chen, Juan, et al.
Publicado: (2023)

Co-isolates of Acinetobacter baumannii complex in polymicrobial infections: a meta-analysis
por: Karakonstantis, Stamatis, et al.
Publicado: (2022)

Acinetobacter baumannii Bloodstream Infections: A Nationwide Study in Israel
por: Nutman, Amir, et al.
Publicado: (2023)

Acinetobacter baumannii Genes Required for Bacterial Survival during Bloodstream Infection
por: Subashchandrabose, Sargurunathan, et al.
Publicado: (2015)

Clinical Characteristics and Prognosis Analysis of Acinetobacter baumannii Bloodstream Infection Based on Propensity Matching
por: Wang, Jinghui, et al.
Publicado: (2022)

Staphylococcus aureus bloodstream infection in a Chinese tertiary-care hospital: A single-center retrospective study
por: Zheng, Cheng, et al.
Publicado: (2023)

The Acinetobacter baumannii group: a systemic review
por: Zhang, Hua-zhong, et al.
Publicado: (2013)

Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study
por: Pan, Sijun, et al.
Publicado: (2018)

Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii
por: Bai, Bing, et al.
Publicado: (2022)

Correction to: Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study
por: Pan, Sijun, et al.
Publicado: (2019)

Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
por: Niu, Tianshui, et al.
Publicado: (2019)

Seasonality and weather dependance of Acinetobacter baumannii complex bloodstream infections in different climates in Brazil
por: Filho, Sebastião Pires Ferreira, et al.
Publicado: (2021)

Polymicrobial community-acquired Acinetobacter baumannii and Burkholderia pseudomallei bacteremia: opportunistic infections with similar risk factors in northern Australia
por: Fairhead, Lee, et al.
Publicado: (2020)

Microbiological Analysis and Mortality Risk Factors in Patients with Polymicrobial Bloodstream Infections
por: Xu, Junhong, et al.
Publicado: (2023)

Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: A Retrospective Observational Study
por: Liu, Fengqi, et al.
Publicado: (2021)

High fever and multi-nodular lung consolidations after whole lung lavage in a patient with pulmonary alveolar proteinosis
por: Zhang, Shufang, et al.
Publicado: (2015)

Effects of the working experience, educational background, professional titles, and hospital grades of intensive care unit doctors on clinical glucocorticoid use in acute respiratory distress syndrome
por: Xuan, Nanxia, et al.
Publicado: (2022)

Resistance Markers and Genetic Diversity in Acinetobacter baumannii Strains Recovered from Nosocomial Bloodstream Infections
por: Martins, Hanoch S. I., et al.
Publicado: (2014)

High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study
por: Han, Hui, et al.
Publicado: (2021)

Molecular epidemiology and carbapenem resistance characteristics of Acinetobacter baumannii causing bloodstream infection from 2009 to 2018 in northwest China
por: Gu, Yihai, et al.
Publicado: (2022)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Gu, Shumin, et al.
Publicado: (2023)

Ten-Year Changes in Bloodstream Infection With Acinetobacter Baumannii Complex in Intensive Care Units in Eastern China: A Retrospective Cohort Study
por: Meng, Xiao, et al.
Publicado: (2021)

Development and clinical validation of a droplet digital PCR assay for detecting Acinetobacter baumannii and Klebsiella pneumoniae in patients with suspected bloodstream infections
por: Zheng, Yang, et al.
Publicado: (2021)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

A fresh look at polymicrobial bloodstream infection in cancer patients
por: Royo-Cebrecos, Cristina, et al.
Publicado: (2017)

Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii
por: Xiao, Shu-Zhen, et al.
Publicado: (2016)

Multicenter Study of the Risk Factors and Outcomes of Bloodstream Infections Caused by Carbapenem-Non-Susceptible Acinetobacter baumannii in Indonesia
por: Anggraini, Dewi, et al.
Publicado: (2022)

Molecular characterisation of Acinetobacter baumannii isolates from bloodstream infections in a tertiary-level hospital in South Africa
por: Lowe, Michelle, et al.
Publicado: (2022)

Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients
por: Li, Henan, et al.
Publicado: (2021)

Cryo-EM structures of Acinetobacter baumannii glycerophospholipid transporter
por: Zhang, Yuanyuan, et al.
Publicado: (2020)

Transcriptome profiling in imipenem-selected Acinetobacter baumannii
por: Chang, Kai-Chih, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1sfb5m73j0bdthvgvg76fnatia